(Q42167271)

English

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

scientific article published on April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 October 2017

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma (English)

1 reference

Europe PubMed Central

17 October 2017

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

17 October 2017

author name string

Jeeyun Lee

1

1 reference

Europe PubMed Central

17 October 2017

Kee-Taek Jang

2

1 reference

Europe PubMed Central

17 October 2017

Taekyu Lim

4

1 reference

Europe PubMed Central

17 October 2017

Young Suk Park

5

1 reference

Europe PubMed Central

17 October 2017

Ho Yeong Lim

6

1 reference

Europe PubMed Central

17 October 2017

Dong-Wook Choi

7

1 reference

Europe PubMed Central

17 October 2017

Won Ki Kang

8

1 reference

Europe PubMed Central

17 October 2017

Keunchil Park

9

1 reference

Europe PubMed Central

17 October 2017

Joon Oh Park

10

1 reference

Europe PubMed Central

17 October 2017

language of work or name

0 references

publication date

1 April 2007

1 reference

Europe PubMed Central

17 October 2017

1 reference

Europe PubMed Central

17 October 2017

109

1 reference

Europe PubMed Central

17 October 2017

1561-1569

1 reference

Europe PubMed Central

17 October 2017

8

1 reference

Europe PubMed Central

17 October 2017

Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Current approaches and future strategies for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

A multispecialty approach to the diagnosis and management of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy and tamoxifen: concurrent or sequential? That is the question

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidermal growth factor receptor in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Unique K-ras mutational pattern in pancreatic adenocarcinoma from Taiwanese patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting RAS signalling pathways in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer. A bull's eye for targeted lung cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22559

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22559

1 reference

Europe PubMed Central

17 October 2017

1 reference

Europe PubMed Central

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42167271&oldid=1935100770"